| Literature DB >> 35624003 |
John M Burnheimer1, Carolyn G Serio2, Brenda H Loo3, Lily A Hartsock4.
Abstract
BACKGROUND: The objective of this study was to investigate the impact of the COVID-19 pandemic on the prevalence and persistence of white spot lesions (WSLs) among patients treated with traditional braces.Entities:
Keywords: COVID-19; Decalcification; Dental caries; Oral hygiene; Orthodontics
Mesh:
Year: 2022 PMID: 35624003 PMCID: PMC9057944 DOI: 10.1016/j.ejwf.2022.03.003
Source DB: PubMed Journal: J World Fed Orthod ISSN: 2212-4438
Fig. 1Examples of pre and post treatment photographs of two patients with pre-existing WSLs, one of which scored negative (A) for developing additional WSLs and one scored positive (B).
Evaluation criteria used for pretreatment and post-treatment oral hygiene scoring
| Oral Hygiene | Pretreatment | Post-treatment |
|---|---|---|
| Good | No visible plaque, no gingivitis | No visible plaque, no hypertrophy, gingival bleeding only because of composite removal |
| Fair | Some visible plaque, isolated areas of gingivitis | Some visible plaque, isolated gingivitis or hypertrophy, gingival bleeding only because of composite removal |
| Poor | Thick and/or generalized plaque, with gingivitis | Multiple areas of visible plaque and/or generalized hypertrophy, gingivitis, and gingival bleeding |
Note:Table 1 was adapted from Julien et al. [12].
Overview of baseline clinical characteristics
| Prelockdown | Postlockdown | |||
|---|---|---|---|---|
| Sex, n (%) | Male | 78 (45.1) | 76 (38.2) | 0.205 |
| Female | 95 (54.9) | 123 (61.8) | ||
| Age (y) mean ± SD | 17.6 ± 9.5 | 16.7 (8.6) | 0.337 | |
| Pretreatment PAR mean ± SD | 20.3 ± 10 | 22.3 ± 11.1 | 0.124 | |
| Treatment duration (mo) mean ± SD | 26.5 ± 9.5 | 27.0 ± 10.5 | 0.628 | |
PAR, peer assessment rating.
Risk factors for the development of white spot lesions
| Developed WSL | |||||
|---|---|---|---|---|---|
| Prelockdown, % | Postlockdown, % | Risk ratio (95% CI) | |||
| Prevalence | Overall | 29.5 | 52.8 | 1.6 (1.2–2.1) | <0.001 |
| Female | 26.3 | 45.5 | 1.7 (1.2–2.6) | 0.005 | |
| Male | 32.1 | 50.0 | 1.6 (1.1–2.3) | 0.027 | |
| Pretreatment WSL | 62.5 | 53.5 | 0.9 (0.5–1.6) | 0.614 | |
| Pretreatment OH | Fair | 61.5 | 66.7 | 1.1 (0.8–1.5) | 0.658 |
| Good | 20.1 | 42.0 | 2.1 (1.4–3.0) | <0.001 | |
| Worsened OH | 69.6 | 81.2 | 1.2 (0.9–1.4) | 0.096 | |
CI, confidence interval; OH, oral hygiene; WSL, white spot lesion.
Percent of patients who developed white spot lesions on the maxillary and mandibular teeth
| WSL location | Prelockdown, % | Postlockdown, % | |
|---|---|---|---|
| Maxilla | 28.30 | 42.70 | 0.005 |
| Mandible | 15.00 | 18.10 | 0.431 |
| Total | 29.40 | 45.20 | 0.002 |
WSL, white spot lesion.
Fig. 2Percent distribution of WSLs pre- and post lockdown in the maxilla versus the mandible.